Quintiles credits IT advances for big deals; Merck Millipore eyes price hike;

> Quintiles CIO Richard Thomas says the CRO has boosted its IT capabilities of late, and that has helped bring in about $400 million in new business. Report

> CMO Merck Millipore is planning to hike its rates between 4% and 6% next year, citing rising costs. News

> Icon ($ICLR) is expanding its early-phase imaging services, unveiling new processes to save time in drug development. More

> AMRI has expanded its clinical supply agreement with Shire ($SHPG) for another 5 years. Neither company disclosed financial terms. Article

> Chinese CRO Tigermed is turning to Merge Healthcare ($MRGE) to streamline its clinical trial management. Release

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

WCG is continuing its buyout run after acquiring clinical trial solutions firm Trifecta Clinical.

London-based uMed has raised nearly $4.8 million from U.K. and U.S. VCs to help healthcare providers participate in more clinical studies.

Amgen has teamed up with cloud-based trial solutions firm Reify Health to help boost patients into its drug studies.